Skip to main content

VANGUARD GROUP INC

Position in QNCX — Quince Therapeutics, Inc.

CIK 102909 Valley Forge, PA

Position in QNCX

as of Dec 31, 2025 · filed Jan 29, 2026
Position Value
$1,396,290,050
+$821,425,888 QoQ
Shares Held
2,084,015
+18.2% QoQ
Ownership
12.8%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 12.977833652828794.ToString("F0")% None 87.02216634717121.ToString("F0")%

Common Shares in QNCX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Dec 31, 2025

VANGUARD GROUP INC holds $67,123,505,993 across 449 Biotechnology names. QNCX ranks #6 (2.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 QNCX
Quince Therapeutics, Inc.
This page
2,084,015 $1,396,290,050

All Filings in QNCX

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2025-12-31 $1,396,290,050 2,084,015
2025-09-30 $574,864,162 1,763,387
2025-06-30 $479,832,540 1,454,038
2025-03-31 $342,015,618 1,285,773
2024-12-31 $475,855,160 1,272,340
2024-09-30 $186,185,369 1,199,648
2024-06-30 $182,193,150 1,214,621
2024-03-31 $239,884,360 1,131,530
2023-12-31 $204,078,210 971,801
2023-09-30 $212,797,984 949,991
2023-06-30 $268,880,591 893,291
2023-03-31 $278,706,792 893,291
2022-12-31 $108,722,013 853,391
2022-09-30 $231,953,596 872,006
2022-06-30 $349,866,672 787,988
2022-03-31 $1,395,815,288 1,127,476
2021-12-31 $2,718,272,280 1,076,970
2021-09-30 $18,568,904,436 1,012,923
2021-06-30 $9,713,161,600 916,336
2021-03-31 $6,174,569,190 856,865
2020-12-31 $3,988,213,476 717,821
2020-09-30 $6,983,760,000 698,376
2020-06-30 $5,554,129,480 599,798
2020-03-31 $4,098,003,768 449,244